Evaluating the expression of IDO and TNF-α and vitamin D levels in diabetic patients cured of MERS-CoV compared to the control groups

https://doi.org/10.53730/ijhs.v6nS1.7655

Authors

  • Muna M. Kadam Department of Chemistry, Faculty of Sciences, University of Al-Qadisiyah, Iraq
  • Zainab N. Al-Abady Department of Chemistry, Faculty of Sciences, University of Al-Qadisiyah, Iraq

Keywords:

COVID-19, Diabetes mellitus, Vitamin D, TNF-α, IDO

Abstract

SARS-CoV-2, the new virus responsible for the current coronavirus 2019 (COVID-19) pandemic, has infected people around the world since the first case was reported in Wuhan, China. As more epidemiological data is collected on COVID-19 patients, factors that increase the severity of infection are identified and reported. It is well known that diabetes is one of the most frequently associated comorbidities with worse outcomes for COVID-19 patients, as it is considered a high-risk aggregate of COVID-19. In addition to low NAD availability and exacerbation of infection. These patients are predisposed to severe COVID-19 pathophysiology due to a metabolic imbalance. The current study looked at the expression of tumor necrosis factor (TNF- α) and IDO (the NAD-biosynthesizing enzyme), as well as serum vitamin D levels and triglycerides. This study included 100 participants: 25 patients with type 2 diabetes who recovered from COVID-19, 25 type 2 diabetic patients who were not infected with COVID-19, and 25 not-diabetic subjects who recovered from COVID-19 compared to 25 healthy control. TNF-α and IDO levels were measured with quantitative PCR, while vitamin D levels were measured with competitive fluorescent immunoassay technology.

Downloads

Download data is not yet available.

References

Jangid, H., Chaturvedi, S., & Khinchi, M. P. (2017). An overview on diabetis mellitus. Asian Journal of Pharmaceutical Research and Development, 1-11.‏American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37(Suppl. 1):S81–S90

Collares, C. V. A., Evangelista, A. F., Xavier, D. J., Takahashi, P., Almeida, R., Macedo, C., ... & Donadi, E. A. (2013). Transcriptome meta-analysis of peripheral lymphomononuclear cells indicates that gestational diabetes is closer to type 1 diabetes than to type 2 diabetes mellitus. Molecular biology reports, 40(9), 5351-5358

Tanko, Y., Suleiman, I., Jimoh, A., Musa, S. A., Mohammed, K. A., Salisu, A. I., & Yusuf, R. (2017). Anti-diabetic effect of ethanol leaf extract of Combretum micranthum blood glucose and oxidative stress biomarkers on alloxan induced diabetic in wistar rats. Bayero Journal of Pure and Applied Sciences, 10(1), 108-114.‏

Rabini, R. A., Fumelli, P., Galassi, R., Dousset, N., Taus, M., Ferretti, G., ... & Valdiguié, P. (1994). Increased susceptibility to lipid oxidation of low-density lipoproteins and erythrocyte membranes from diabetic patients. Metabolism, 43(12), 1470-1474.‏

Muller, L. M. A. J., Gorter, K. J., Hak, E., Goudzwaard, W. L., Schellevis, F. G., Hoepelman, A. I. M., & Rutten, G. E. H. M. (2005). Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clinical infectious diseases, 41(3), 281-288.‏

Allard, R., Leclerc, P., Tremblay, C., & Tannenbaum, T. N. (2010). Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes care, 33(7), 1491-1493.‏

Zimmet, P. Z., Magliano, D. J., Herman, W. H., & Shaw, J. E. (2014). Diabetes: a 21st century challenge. The lancet Diabetes & endocrinology, 2(1), 56-64.‏

Misra, S., & Oliver, N. S. (2015). Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis. Diabetic Medicine, 32(1), 14-23.

‏ Xiao, F., Sun, J., Xu, Y., Li, F., Huang, X., Li, H., ... & Zhao, J. (2020). Infectious SARS-CoV-2 in feces of patient with severe COVID-19. Emerging infectious diseases, 26(8), 1920.‏

Abu-Ashour, W., Twells, L. K., Valcour, J. E., & Gamble, J. M. (2018). Diabetes and the occurrence of infection in primary care: a matched cohort study. BMC infectious diseases, 18(1), 1-8.

‏ Coronavirus, E. (2020). 13,968 Cases and 223 Deaths: https://www. worldometers. info/coronavirus/country/ethiopia. Accessed on, 27.‏

Sohrabi, C., Alsafi, Z., O’Neill, N., Khan, M., Kerwan, A., Al-Jabir, A.,Iosifidis, C., & Agha, R. (2020). World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery, 76(February), 71–76.

Jia HP, Look DC, Shi L, Shi ML, Hickey M, et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol 2005;79:14614–21.

Misra, S., & Oliver, N. S. (2015). Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis. Diabetic Medicine, 32(1), 14-23.

‏ Bakker, B. M., Overkamp, K. M., van Maris, A. J., Kötter, P., Luttik, M. A., van Dijken, J. P., & Pronk, J. T. (2001). Stoichiometry and compartmentation of NADH metabolism in Saccharomyces cerevisiae. FEMS microbiology reviews, 25(1), 15-37.‏

Chiarugi A, Dölle C, Felici R, Ziegler M.2012. The NAD metabolome--a key determinant of cancer cell biology. Nat Rev Cancer. 12:741–52.

Xu P, Sauve Aa. 2010. Vitamin B3, the nicotinamide adenine dinucleotides and aging. Mech Ageing Dev. 131:287–98.

Van Gool, F., Galli, M., Gueydan, C., Kruys, V., Prevot, P.P., Bedalov, A., Mostoslavsky, R., Alt, F.W., De Smedt, T. and Leo, O. Intracellular NAD+ levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner. Nat. Med. 2009; 15, 206–210

Iqbal, J., & Zaidi, M. (2006). TNF regulates cellular NAD+ metabolism in primary macrophages. Biochemical and biophysical research communications, 342(4), 1312-1318.‏

Dölle, C., Rack, J. G., & Ziegler, M. (2013). NAD and ADP‐ribose metabolism in mitochondria. The FEBS journal, 280(15), 3530-3541.‏

Sugimoto, H., Oda, S. I., Otsuki, T., Hino, T., Yoshida, T., & Shiro, Y. (2006). Crystal structure of human indoleamine 2, 3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase. Proceedings of the National Academy of Sciences, 103(8), 2611-2616.‏

Mbongue, J. C., Nicholas, D. A., Torrez, T. W., Kim, N. S., Firek, A. F., & Langridge, W. H. (2015). The role of indoleamine 2, 3-dioxygenase in immune suppression and autoimmunity. Vaccines, 3(3), 703-729.‏

Shirey, K. A., Jung, J. Y., Maeder, G. S., & Carlin, J. M. (2006). Upregulation of IFN-γ receptor expression by proinflammatory cytokines influences IDO activation in epithelial cells. Journal of interferon & cytokine research, 26(1), 53-62.‏

Al-Shabany, A. J., & Al-Abady, Z. N. (2018). NAD (+) Levels Are Depleted in DMSO Differentiated Leukemia Cells. RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 9(2), 411-418.‏

Ouyang, Y., Yin, J., Wang, W., Shi, H., Shi, Y., Xu, B., ... & Chen, D. (2020). Downregulated gene expression spectrum and immune responses changed during the disease progression in patients with COVID-19. Clinical Infectious Diseases, 71(16), 2052-2060.‏

Nigar, S., Shah, S. T., Setu, M. A. A., Dip, S. D., Ibnat, H., Islam, M. T., ... & Hossain, M. A. (2021). Relative expression of proinflammatory molecules in COVID‐19 patients who manifested disease severities. Journal of Medical Virology, 93(10), 5805-5815.‏

Adams, J. S., Ren, S., Liu, P. T., Chun, R. F., Lagishetty, V., Gombart, A. F., ... & Hewison, M. (2009). Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. The Journal of Immunology, 182(7), 4289-4295.‏

Chen, G., Wu, D. I., Guo, W., Cao, Y., Huang, D., Wang, H., ... & Ning, Q. (2020). Clinical and immunological features of severe and moderate coronavirus disease 2019. The Journal of clinical investigation, 130(5), 2620-2629.‏

Cantorna, M. T., Snyder, L., Lin, Y. D., & Yang, L. (2015). Vitamin D and 1, 25 (OH) 2D regulation of T cells. Nutrients, 7(4), 3011-3021.‏

Liu, N., Sun, J., Wang, X., Zhang, T., Zhao, M., & Li, H. (2021). Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis. International Journal of Infectious Diseases, 104, 58-64.‏

Chalmers, J. D., McHugh, B. J., Docherty, C., Govan, J. R., & Hill, A. T. (2013). Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis. Thorax, 68(1), 39-47.‏

Mamani, M., Muceli, N., Basir, H. R. G., Vasheghani, M., & Poorolajal, J. (2017). Association between serum concentration of 25-hydroxyvitamin D and community-acquired pneumonia: a case-control study. International journal of general medicine, 10, 423.‏

Cheng, J. B., Levine, M. A., Bell, N. H., Mangelsdorf, D. J., & Russell, D. W. (2004). Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proceedings of the National Academy of Sciences, 101(20), 7711-7715.‏

Ahmad, J., Hameed, B., Das, G., Siddiqui, M. A., & Ahmad, I. (2005). Postprandial hypertriglyceridemia and carotid intima–media thickness in north Indian type 2 diabetic subjects. Diabetes research and clinical practice, 69(2), 142-150.‏

Després, J. P. (1998). The insulin resistance—dyslipidemic syndrome of visceral obesity: effect on patients' risk. Obesity research, 6(S1), 8S-17S.‏

Li, Y., He, F., Zhou, N., Wei, J., Ding, Z., Wang, L., ... & Zhu, W. (2020). Organ function support in patients with coronavirus disease 2019: Tongji experience. Frontiers of medicine, 14(2), 232-248.‏

Published

21-05-2022

How to Cite

Kadam, M. M., & Al-Abady, Z. N. (2022). Evaluating the expression of IDO and TNF-α and vitamin D levels in diabetic patients cured of MERS-CoV compared to the control groups. International Journal of Health Sciences, 6(S1), 10283–10292. https://doi.org/10.53730/ijhs.v6nS1.7655

Issue

Section

Peer Review Articles